Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non Operating Income: 2013-2025

Historic Non Operating Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to -$3.8 million.

  • Amphastar Pharmaceuticals' Non Operating Income rose 59.35% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.3 million, marking a year-over-year increase of 32.22%. This contributed to the annual value of -$15.7 million for FY2024, which is 38.91% up from last year.
  • Amphastar Pharmaceuticals' Non Operating Income amounted to -$3.8 million in Q3 2025, which was down 33.63% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Non Operating Income registered a high of $13.3 million during Q3 2021, and its lowest value of -$12.6 million during Q4 2023.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Non Operating Income value was -$4.1 million (recorded in 2023), while the average stood at -$4.4 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 1,330.54% in 2023, then skyrocketed by 1,618.21% in 2024.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Non Operating Income stood at $2.9 million in 2021, then rose by 15.58% to $3.4 million in 2022, then tumbled by 474.26% to -$12.6 million in 2023, then surged by 90.65% to -$1.2 million in 2024, then spiked by 59.35% to -$3.8 million in 2025.
  • Its Non Operating Income stands at -$3.8 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$6.4 million for Q1 2025.